Clinical Trials · NCT00223717

Treatment of Supine Hypertension in Autonomic Failure

CompletedPhase 1Desmopressin (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Vanderbilt University
Enrollment
152
Start date
Jan 2001
Locations
1 site, United States
Primary endpoint
Decrease in supine systolic blood pressure
View Desmopressin compound reference